What’s Behind the Surge in Qualigen Stock (QLGN) Today? Crypto Partnership Fuels the Increase
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2025
0mins
Source: TipRanks
Partnership Announcement: Qualigen Therapeutics has partnered with BitGo to manage a crypto treasury strategy, marking a significant shift from its traditional biotech focus.
Stock Performance: Following the announcement, QLGN shares surged over 100% in pre-market trading, indicating strong investor interest after a period of weak stock performance.
Analyst Ratings: Despite the positive market reaction, an AI analyst from TipRanks rates QLGN as Underperform due to concerns over weak revenue, heavy losses, and financial strain.
Future Outlook: The analyst suggests that recent investments and leadership changes could potentially lead to improvements for the company moving forward.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
